ACT-335827 is an orally available, brain-penetrant, orexin type 1 receptor-selective antagonist, with IC50 values of 6 nM for OXR1 and 417 nM for OXR2. It is suitable for studies related to neurological disorders [1].
Molecular Weight:
518.64
CAS Number:
[1354039-86-3]
Formula:
C31H38N2O5
Target:
OX Receptor|||Others
T21850
* VAT and and shipping costs not included. Errors and price changes excepted